Amedisys Share Holder Equity 2010-2024 | AMED

Amedisys share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Amedisys Annual Share Holder Equity
(Millions of US $)
2023 $1,120
2022 $1,107
2021 $976
2020 $811
2019 $642
2018 $483
2017 $516
2016 $461
2015 $410
2014 $398
2013 $372
2012 $454
2011 $520
2010 $880
2009 $736
Amedisys Quarterly Share Holder Equity
(Millions of US $)
2024-03-31 $1,143
2023-12-31 $1,120
2023-09-30 $1,094
2023-06-30 $1,061
2023-03-31 $1,133
2022-12-31 $1,107
2022-09-30 $1,070
2022-06-30 $1,039
2022-03-31 $1,021
2021-12-31 $976
2021-09-30 $949
2021-06-30 $876
2021-03-31 $790
2020-12-31 $811
2020-09-30 $758
2020-06-30 $722
2020-03-31 $680
2019-12-31 $642
2019-09-30 $603
2019-06-30 $563
2019-03-31 $521
2018-12-31 $483
2018-09-30 $445
2018-06-30 $409
2018-03-31 $550
2017-12-31 $516
2017-09-30 $513
2017-06-30 $493
2017-03-31 $483
2016-12-31 $461
2016-09-30 $446
2016-06-30 $428
2016-03-31 $411
2015-12-31 $410
2015-09-30 $394
2015-06-30 $380
2015-03-31 $367
2014-12-31 $398
2014-09-30 $383
2014-06-30 $371
2014-03-31 $363
2013-12-31 $372
2013-09-30 $378
2013-06-30 $465
2013-03-31 $462
2012-12-31 $454
2012-09-30 $572
2012-06-30 $541
2012-03-31 $530
2011-12-31 $520
2011-09-30 $512
2011-06-30 $930
2011-03-31 $904
2010-12-31 $880
2010-09-30 $848
2010-06-30 $828
2010-03-31 $784
2009-12-31 $736
2009-09-30 $686
2009-06-30 $643
2009-03-31 $598
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.999B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00